European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Alliance for Life Sciences: From Strategies to Actions in Central and Eastern Europe

Descripción del proyecto

Fomento de la investigación e innovación sanitaria

La investigación e innovación (I+i) desempeña un papel esencial a la hora de abordar los retos de la sociedad de Europa, incluidos el de garantizar la salud y el bienestar de los ciudadanos europeos. Sin embargo, y a pesar de cuantiosas inversiones, aún existen diferencias entre países en el rendimiento de la I+i. En el sector sanitario, la brecha en I+i puede afectar sobremanera a la calidad de la salud y la vida de los ciudadanos europeos. El proyecto financiado con fondos europeos A4L_ACTIONS, que continua el éxito de Alliance4Life, tiene por objeto abordar la brecha de I+i en el sector sanitario al mejorar la cultura, la gobernanza, el reconocimiento y el potencial de innovación de las instituciones de investigación sanitaria de los países de Europa Central y Oriental de menor rendimiento. Esto ayudará a aumentar su atractivo y a posibilitar colaboraciones con países europeos avanzados.

Objetivo

The gap in Research and Innovation (R&I) performance, which persists despite considerable investments from the European Structural and Investment Funds (ESIF) in the lower-performing regions of the EU, is an issue with major socio-economic and political consequences. In Health R&I the gap has a profound impact on distribution of funding from the EU Framework Programmes as well as on hindering the EU-wide impact of R&I on health and quality of life.

With A4L_ACTIONS, we aim to address roots of this situation in the lower-performing Central and Eastern Europe (CEE) by improving culture, governance, recognition and innovation potential of the health research-performing institutions. Our goal is to increase their attractiveness for collaborations with advanced Europe and create spill-over effects in the whole region. As the Alliance4Life, we are an established network of progressive health research institutions in CEE and a source of successfully piloted good practice. By building upon our results and impact achieved so far, we will convert our recommendations and strategies into actions as follows:

- Culture fostering excellence: piloting peer-evaluation and assessment of institutional practice as a strategic management tool, professionalizing research administration;

- Recognition and trust towards CEE: attracting advanced partners to identified pockets of excellence, supporting scientific ideas originating in CEE, initiating new international projects and collaborations with industry;

- Career policy nurturing talent: training and networking next generation of leaders, upgrading institutional career systems;

- Impact on innovation: raising the competences of Technology Transfer specialists, creating industry relations platform linking academia and industry;

- Spill-over effects: sharing, inspiring, communicating with stakeholders and policy makers; using the established networks to gain advice, new collaborations and EU-wide impact.

Convocatoria de propuestas

H2020-SC1-BHC-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-SC1-2020-Single-Stage-RTD

Régimen de financiación

CSA - Coordination and support action

Coordinador

Masarykova univerzita
Aportación neta de la UEn
€ 561 476,25
Dirección
Zerotinovo namesti 9
601 77 Brno
Chequia

Ver en el mapa

Región
Česko Jihovýchod Jihomoravský kraj
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 561 476,25

Participantes (11)